Charles Morris Net Worth

The estimated Net Worth of Charles Q Morris is at least $2.48 Миллион dollars as of 26 February 2020. Charles Morris owns over 1,256 units of Radius Recycling stock worth over $495,362 and over the last 11 years he sold RDUS stock worth over $321,271. In addition, he makes $1,660,660 as Chief Medical Officer at Radius Recycling.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Charles Morris RDUS stock SEC Form 4 insiders trading

Charles has made over 7 trades of the Radius Recycling stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 1,256 units of RDUS stock worth $22,520 on 26 February 2020.

The largest trade he's ever made was exercising 13,672 units of Radius Recycling stock on 20 February 2014 worth over $163,107. On average, Charles trades about 3,461 units every 152 days since 2013. As of 26 February 2020 he still owns at least 33,744 units of Radius Recycling stock.

You can see the complete history of Charles Morris stock trades at the bottom of the page.

Charles Morris biography

Dr. Charles Q. Morris serves as Chief Medical Officer of the Company. Prior to joining Radius, Dr. Morris served as Chief Development Officer at PsiOxus Therapeutics, Ltd. (“PsiOxus”), a cancer gene therapy company, from September 2016. Prior to PsiOxus, he was Chief Development Officer at ImmunoGen, Inc., a biotechnology company focused on antibody-drug conjugate therapeutics, from November 2012 to August 2016. Prior to that, Dr. Morris was Chief Medical Officer at Allos Therapeutics, Inc., a biopharmaceutical company focused on anti-cancer therapeutics, and served in various leadership positions at Cephalon, a biopharmaceutical company, and AstraZeneca Pharmaceuticals (formerly Zeneca Pharmaceuticals), a pharmaceutical company. Dr. Morris is a graduate of Sheffield University Medical School and is a Member of the Royal College of Physicians of London.

What is the salary of Charles Morris?

As the Chief Medical Officer of Radius Recycling, the total compensation of Charles Morris at Radius Recycling is $1,660,660. There are no executives at Radius Recycling getting paid more.

How old is Charles Morris?

Charles Morris is 55, he's been the Chief Medical Officer of Radius Recycling since 2018. There are 6 older and 5 younger executives at Radius Recycling. The oldest executive at Radius Recycling Inc. is Dr. John Thomas Potts Jr., DSc, M.D., 89, who is the Founder & Member of the Scientific Advisory Board.

What's Charles Morris's mailing address?

Charles's mailing address filed with the SEC is C/O RADIUS HEALTH, INC., 950 WINTER STREET, WALTHAM, MA, 02451.

Insiders trading at Radius Recycling

Over the last 12 years, insiders at Radius Recycling have traded over $1,066,622 worth of Radius Recycling stock and bought 11,047,648 units worth $180,729,288 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., Growth N Vbb Biotech Ag Bio... и Capital Management Lp Rosen.... On average, Radius Recycling executives and independent directors trade stock every 34 days with the average trade being worth of $1,552,483. The most recent stock trade was executed by Stefano R. Gaggini on 6 May 2024, trading 1,021 units of RDUS stock currently worth $18,960.

What does Radius Recycling do?

founded in 1906 as a one-man scrap metal operation, schnitzer steel industries, inc., has become one of the nation's largest recyclers of scrap metal, a leading provider of used and recycled auto parts and a manufacturer of finished steel products. with a rapidly growing national and global reach, the company achieved $2.5 billion in revenues in fiscal 2014 and was ranked #853 in the 2015 fortune 1000 list of companies. schnitzer steel common stock is traded on the nasdaq stock market under the symbol schn. with corporate headquarters based in portland, oregon, the company is split into three vertically integrated business units, the metals recycling business, the auto parts business and the steel manufacturing business. career site: http://www.schnitzersteel.com/careers.aspx

Complete history of Charles Morris stock trades at Immunogen и Radius Recycling

Radius Recycling executives and stock owners

Radius Recycling executives and other stock owners filed with the SEC include:

• Charles Morris,
  Chief Medical Officer
• Chhaya Shah,
  Sr. VP & Chief Bus. Officer
• G. Kelly Martin,
  CEO, Pres & Director
• Salvador Grausso III,
  Sr. VP & Head of U.S. Patient access
• Danielle Holtschlag,
  VP of Sales & Head of U.S. Sales Channels
• Owen Hughes,
  Independent Chairman of the board
• Elhan Webb,
  Investor Relations
• Sean Murphy,
  Director
• Chhaya Shah,
  Senior Vice President - Technical Operations
• Dan Dolan,
  Principal Financial Officer, Principal Accounting Officer, Treasurer
• G. Kelly Martin,
  President, Chief Executive Officer, Director
• Peter A. Schwartzman,
  Head of Corp. Fin.
• Mark William Conley CPA,
  VP, CFO, Principal Accounting Officer & Treasurer
• Averi Price,
  Gen. Counsel, Chief Compliance Officer & Sec.
• Ethan Holdaway,
  Head of Investor Relations
• Steven Helwig,
  Principal Fin. & Accounting Officer and Interim Treasurer
• Dr. John A. Katzenellenbogen,
  Founder & Member of the Scientific Advisory Board
• Dr. Michael Rosenblatt M.D.,
  Founder, Board Observer & Member of Scientific Advisory Board
• Dr. John Thomas Potts Jr., DSc, M.D.,
  Founder & Member of the Scientific Advisory Board
• Dr. Stavros C. Manolagas,
  Founder & Member of the Scientific Advisory Board
• Growth N Vbb Biotech Ag Bio...,
  
• Lorraine A. Fitzpatrick,
  Chief Medical Officer
• Alan H Auerbach,
  Director
• Bio Ventures Iv Llc Scopa J...,
  
• Ansbert Gadicke,
  Director
• Robert Ward,
  President & Chief Exec Officer
• Gregory C. Williams,
  Chief Development Officer
• Debasish Roychowdhury,
  Director
• Brent Hatzis Schoch,
  Sr. VP, General Counsel
• Kurt Graves,
  Director
• Cathy Friedman,
  Director
• Willard H Dere,
  Director
• Bioventures Iii Llchenner D...,
  
• Luke Evnin,
  10% owner
• Dinesh Purandare,
  SVP,Global Oncology/Commercial
• David P. Snow,
  Chief Commercial Officer
• Jose Carmona,
  Chief Financial Officer
• Anthony Rosenberg,
  Director
• Jean Pierre Garnier,
  Director
• Nicholassimon Nicholas J Ii...,
  
• Gary Hattersley,
  Sr. VP & Chief Scientific Off.
• Brian Nicholas Harvey,
  Sr. Vice President & CFO
• Gregory R Friedman,
  
• Rhonda D Hunter,
  
• David L Jahnke,
  
• Jesper Hoeiland,
  President and CEO
• Danielle Holtschlag,
  Vice President, Sales
• Joseph Francis Kelly,
  Sr. VP of Sales and Marketing
• Jessica Hopfield,
  Director
• Glenda J Minor,
  
• Michael W Sutherlin,
  
• Bioscience Iii, L.P.F2 Bios...,
  
• Martin Muenchbach,
  Director
• Morana Jovan Embiricos,
  Director
• Bioscience Iv L.P.F2 Biosci...,
  
• Bioscience Iii, L.P.F2 Bios...,
  
• Alan G Harris,
  Executive Medical Officer
• Elizabeth Stoner,
  Director
• Bioventures Iii Llchenner D...,
  
• Bioscience Iv L.P.F2 Biosci...,
  
• Mark Durand,
  Chief Commercial Officer
• Bio Ventures Iv Llc Scopa J...,
  
• Bio Ventures Iv Llc Scopa J...,
  
• Bioventures Iii Llcmpm Biov...,
  
• Leslie L Shoemaker,
  
• Target N Vbb Biotech Ag Bio...,
  
• Machelle Sanders,
  Director
• Sal Grausso,
  Chief Commercial Officer
• James George Chopas,
  Principal Finance Accounting
• Steven Helwig,
  Principal Financial Officer
• Capital Management Lp Rosen...,
  
• Mark William Conley,
  VP, Chief Financial Officer
• Susan Vissers Lisa,
  Director
• Jennifer Jarrett,
  Director
• Elizabeth Messersmith,
  Senior Vice President
• Tamara L. Lundgren,
  Chairman, President & CEO
• James Matthew Vaughn,
  SVP, GC, CCO, Corp. Secretary
• Steven Heiskell,
  SVP & President, Recycling P&S
• Mark Schuessler,
  VP and CAO
• Brian Souza,
  SVP, Chief Ops Mgmt Officer
• Richard Peach,
  EVP, Chief Strategy Officer
• Wilson D Erich,
  SVP, Chief HR Officer
• Stefano R. Gaggini,
  SVP, CFO